drugset / Trial / NCT00797953
Phase II Multi-Center Study of T89 to Treat Chronic Stable Angina
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine the anti-angina effect and dose response of T89, a 2-herb botanical drug product, in patients with chronic stable angina pectoris in the United States.
Timeline
- Start
- 2007-02
- Primary completion
- 2009-12
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | T89 | Traditional medicine (herbal / TCM) | 125 mg | Oral |
| Subject | T89 | Traditional medicine (herbal / TCM) | 187.5 mg | Oral |